#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Biosimilar insulin glargine added to treatment with oral antidiabetics


Authors: Marek Macko
Authors‘ workplace: DIABETOL, s. r. o., Prešov
Published in: Diab Obez 2020; 20(40): 110-111
Category: Case studies


Sources
  1. Martinka E, Uličiansky V, Mokáň M et al. Konsenzuálne terapeutické odporúčanie Slovenskej diabetologickej spoločnosti pre diabetes mellitus 2. typu (2018). Forum Diab 2018; 7(1): 47–68.
  2. Davies MJ, D‘Alessio DA, Fradkin J et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41(12): 2669–2701. Dostupné z DOI: <https://doi.org/10.2337/dci18–0033>.
  3. Tieu C, Lucas EJ, DePaola M et al. Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review. PLoS One 2018; 13(4): e0195012. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0195012>.
Labels
Diabetology Obesitology

Article was published in

Diabetes and obesity

Issue 40

2020 Issue 40

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#